• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THE SPECTRANETICS CORPORATION STELLAREX 0.014 OTW DRUG-COATED ANGIOPLASTY BALLOON; DCB PTA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THE SPECTRANETICS CORPORATION STELLAREX 0.014 OTW DRUG-COATED ANGIOPLASTY BALLOON; DCB PTA CATHETER Back to Search Results
Model Number AA14SX030150150
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Renal Failure (2041); Post Operative Wound Infection (2446)
Event Date 01/14/2021
Event Type  Death  
Manufacturer Narrative
The patient's date of birth, ethnicity, and race are unknown.This information was not available from the facility.Foreign- (b)(6)/ study name: (b)(6) - patient id #: (b)(6).Pma number is not applicable.The device is a commercial product with a ce mark that was used as part of a clinical study.During the index procedure, the product worked as intended and the device was discarded, thus no product evaluation was required.Although the cause of death is unrelated to the study device, death is listed in the ifu as a potential complications/ adverse events.
 
Event Description
It was reported through a clinical study that during the index procedure on (b)(6) 2021, three stellarex catheters (3011416935-2022-00003, 3011416935-2022-00004) were used to treat the target lesion of the right proximal and distal anterior tibial artery.Approximately 13 months post index procedure, the patient expired due to infection after a major amputation of a non-target limb on (b)(6) 2022.The physician reported this is not related to the study device or procedure.This adverse event is being submitted because the patient expired due to infection after a major amputation of a non-target limb.This is being reported as a follow-up to the clinical study.
 
Event Description
It was reported that the primary cause of death was a combination of the comorbidities, vascular disease and renal function worsening.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STELLAREX 0.014 OTW DRUG-COATED ANGIOPLASTY BALLOON
Type of Device
DCB PTA CATHETER
Manufacturer (Section D)
THE SPECTRANETICS CORPORATION
6655 wedgwood road north
suite 105
maple grove MN 55311
Manufacturer (Section G)
SPECTRANETICS
6655 wedgwood road north
suite 105
maple grove MN 55311
Manufacturer Contact
diana melliza galvez
6655 wedgwood road north
suite 105
maple grove, MN 55311
MDR Report Key13826816
MDR Text Key287521501
Report Number3011416935-2022-00002
Device Sequence Number1
Product Code ONU
Combination Product (y/n)Y
Reporter Country CodeNL
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/04/2024
Device Model NumberAA14SX030150150
Device Catalogue NumberAA14SX030150150
Device Lot NumberF7F19M26A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 02/21/2022
Initial Date FDA Received03/19/2022
Supplement Dates Manufacturer Received05/18/2022
Supplement Dates FDA Received05/21/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/04/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age70 YR
Patient SexMale
Patient Weight82 KG
-
-